Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 6.55
+0.18 (2.83%)
Aug 4, 2026, 3:04 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 2.65 billion as of August 4, 2026. Its market cap has decreased by -41.18% in one year.
Market Cap
2.65B
Enterprise Value
2.52B
Revenue
271.53M
Ranking
n/a
PE Ratio
388.48
Stock Price
6.55
ChartMarket Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 2.65B, a decrease of -81.63%. That is a compound annual growth rate of -26.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.65B | -30.39% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Serum Bio-Technology | 2.97B |
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Guanhao Biotech | 2.94B |
| Qingdao Vland Biotech INC. | 2.92B |
| Novoprotein Scientific | 2.82B |
| Guangdong VTR Bio-Tech | 2.80B |
| Hubei Goto Biopharm Group | 2.80B |
| Beijing Kawin Technology Share-Holding | 2.72B |